Table 4

Comparisons of area under curves (AUCs) between patients with length of hospital stay (LOS) ≤6 and >6 days, respectively, based on two-sample t-test

Parameters and thresholdsLOS ≤6 days (n=61)LOS >6 days (n=41)P value
AUC >0 (n)AUC median (Q1–Q3) (unit*min)AUC >0 (n)AUC median (Q1–Q3) (unit*min)
MAP <50 mm Hg1411 (5–25)2326 (9–53)0.4
MAP <60 mm Hg2915 (4–36)3243 (23–144)0.2
MAP <70 mm Hg4483 (34–227)41291 (130–441)0.06
MAP >100 mm Hg51200 (42–517)39324 (100–656)0.2
MAP >110 mm Hg41123 (56–265)36154 (82–501)0.08
MAP >120 mm Hg3682 (29–171)33113 (52–338)0.047
Temp <35°C2243 (6–94)2234 (16–46)0.5
Temp <35.5°C4051 (9–144)3063 (17–129)0.3
Temp <36°C50106 (42–184)35118 (55–245)0.2
Temp >37°C1417 (6–31)1537 (6–54)0.6
Temp >37.5°C421 (9–32)44 (2–5)0.05
Temp >38°C1NA0NANA
SpO<90%58 (2–53)532 (32–928)0.3
SpO<95%716 (2–94)941 (1–45)0.3
HR <40 bpm0NA21452 (1–2904)NA
HR <50 bpm1535 (1–100)921 (11–518)0.2
HR <60 bpm35211 (32–1107)18313 (22–1180)0.5
HR >90 bpm9128 (18–264)14351 (210–508)0.2
HR >100 bpm790 (7–189)11142 (39–164)0.3
HR >110 bpm649 (15–58)836 (8–65)0.8
PI <0.5196 (1–10)214 (0.3–23)0.6
PI <13814 (3–76)2740 (8–130)0.1
PI >6145 (0.3–35)113 (1–22)0.1
PI >10397 (0.2–217)0NANA
iVt <5 mL/kg61421 (340–552)40566 (443–816)0.0001
iVt <6 mL/kg61666 (535–904)40868 (732–1241)0.0003
iVt >8 mL/kg0NA1NANA
iVt >9 mL/kg0NA1NANA
iVt >10 mL/kg0NA0NANA
aVt <5 mL/kg458 (3–44)3411 (5–72)0.4
aVt <6 mL/kg5598 (8–213)39116 (15–335)0.3
aVt >8 mL/kg181 (1–3)143 (1–24)0.2
aVt >9 mL/kg101 (0.3–4)90.1 (0.04–7)0.3
aVt >10 mL/kg80.07 (0.03–4)353 (2–59)0.01
Ppeak <10 cmH2O275 (1–10)198 (3–14)0.3
Ppeak <15 cmH2O3917 (5–55)2919 (7–152)0.2
Ppeak >25 cmH2O2012 (2–161)1228 (3–177)0.5
Ppeak >30 cmH2O810 (2–51)471 (23–106)0.8
Ppeak >35 cmH2O1NA38 (2–18)0.3
PEEP <3 cmH2O325 (2–74)213 (1–9)0.6
PEEP >7 cmH2O115 (1–59)631 (12–295)0.1
PEEP >10 cmH2O39 (0.1–31)32 (1–3)0.3
EtCO>25 mm Hg2216 (7–36)1711 (8–27)0.5
EtCO>30 mm Hg3421 (5–29)2825 (12–57)0.3
EtCO>40 mm Hg3950 (10–212)2481 (13–349)0.9
EtCO>45 mm Hg2112 (3–153)1352 (18–138)0.6
FiO<0.3534 (0.2–245)31524 (11–2532)0.2
FiO<0.451378 (60–157)852 (12–1674)0.1
FiO>0.75571189 (242–3539)391715 (672–4212)0.8
FiO>0.8552460 (89–2206)34706 (411–2431)0.8
SctO<50%1NA574 (74–213)0.7
SctO<55%426 (6–260)932 (16–232)0.5
SctO<60%11161 (28–246)1669 (20–492)0.5
SctO>75%4592 (7–235)23202 (46–505)0.1
SctO>80%2419 (6–46)1311 (2–88)0.3
SctO>85%421 (6–36)459 (13–140)0.2
SctO>90%0NA23 (2–5)NA
SstO<50%859 (1–2632)890 (12–1186)0.4
SstO<55%11130 (29–2328)1123 (16–1682)0.4
SstO<60%15213 (54–1388)1741 (18–675)0.3
SstO>75%50926 (198–1903)371130 (343–2297)0.7
SstO>80%40337 (95–971)31595 (97–1071)0.5
SstO>85%23109 (11–463)22191 (20–478)0.7
SstO>90%54 (1–5)425 (15–65)0.1
  • Only patients whose AUCs were >0 were included in analysis.

  • NA, not assessable; Q1, first quantile; Q3,  third quantile.